GSK has claimed approval in the EU for Exdensur, a long-acting respiratory drug that is considered one of its top growth prospects. The approval of Exdensur (depemokimab) for severe asthma and chronic ...
JACKSON , MS, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- As the warmer weather of spring approaches, so does ...
Children with food allergy who used omalizumab plus oral immunotherapy vs. omalizumab alone had similar rates of allergen ...
Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...
For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...
A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.
"Today's approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment," said Iilun Murph ...
Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.
Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...
Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results